# Cerebrolysin CARS trial: arm recovery after stroke

Source: https://pepvault.app/research/cerebrolysin-cars-2016

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Cerebrolysin](https://pepvault.app/research#cerebrolysin)

Randomized trial · people

# Cerebrolysin: better arm function at day 90 after stroke in CARS

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

One placebo-controlled trial found better arm recovery after stroke when Cerebrolysin was added to early rehab, but it was exploratory and still needs a larger trial to confirm it.

- **Kind:** Randomized trial
- **Studied in:** People
- **Published:** 2016
- **Journal:** Stroke

## What they tested

The team tested whether stroke patients given Cerebrolysin had better arm and hand movement at day 90 than patients given a placebo.

## How the study was done

A randomized, double-blind, placebo-controlled phase II trial at several centers, in patients who had just had a stroke. They got Cerebrolysin (30 mL/d) or saline placebo once a day for 21 days, starting 24 to 72 hours after the stroke, and all joined a standard 21-day rehab program.

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At day 90, the Cerebrolysin group scored higher than the placebo group on the Action Research Arm Test, a measure of arm and hand use. The team rated this a large advantage, with an effect size (a Mann-Whitney estimator) of 0.71 and a 95% confidence interval running from 0.63 to 0.79 (P<0.0001). When 12 outcome scales of overall status were combined, Cerebrolysin came out ahead by a small-to-medium margin, with an estimator of 0.62 (95% confidence interval from 0.58 to 0.65, P<0.0001). Only 3.8% of patients dropped out early, and safety was similar to placebo.

## What it doesn’t show

This was an exploratory trial with a fairly small number of patients, so the team says a large trial is needed to confirm it. All patients started treatment within days of the stroke alongside rehab, so it does not show effects in later stroke recovery or without rehab.

## The paper

Muresanu et al. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke. 2016.

- [PubMed (PMID 26564102)](https://pubmed.ncbi.nlm.nih.gov/26564102/)
- [The paper (DOI 10.1161/STROKEAHA.115.009416)](https://doi.org/10.1161/STROKEAHA.115.009416)

## The compound

- [Cerebrolysin: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)

## With this study

### Cerebrolysin

- [Cerebrolysin: the full reference](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)

### Studies

- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018)
- [Cerebrolysin beat placebo on global change in Alzheimer's at 6 months](https://pepvault.app/research/cerebrolysin-gauthier-2015)
- [All 4 studies](https://pepvault.app/research#cerebrolysin)

### Compared with

- [Semax vs Cerebrolysin](https://pepvault.app/peptides/compare/semax-vs-cerebrolysin)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Cerebrolysin

- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018) Meta-analysis · people · 2018
- [Cerebrolysin beat placebo on global change in Alzheimer's at 6 months](https://pepvault.app/research/cerebrolysin-gauthier-2015) Meta-analysis · people · 2015
- [Cerebrolysin: no overall benefit in acute ischemic stroke at 90 days](https://pepvault.app/research/cerebrolysin-heiss-2012) Randomized trial · people · 2012
- [Every study on Cerebrolysin](https://pepvault.app/research#cerebrolysin)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Cerebrolysin

- [Cerebrolysin: the full reference](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)

### Studies

- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018)
- [Cerebrolysin beat placebo on global change in Alzheimer's at 6 months](https://pepvault.app/research/cerebrolysin-gauthier-2015)
- [All 4 studies](https://pepvault.app/research#cerebrolysin)

### Compared with

- [Semax vs Cerebrolysin](https://pepvault.app/peptides/compare/semax-vs-cerebrolysin)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Cerebrolysin](https://pepvault.app/research#cerebrolysin)

## The library

- [Cerebrolysin](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
